603882 金域医学
2026/06 - 中期
人民币(K¥)
2025/12
人民币(K¥)
2024/12
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
经营活动产生之现金流量净额242,6201,202,009906,3481,230,8211,947,843
投资活动产生之现金流量净额(220,656)(370,972)(455,529)(634,534)(848,369)
筹资活动产生之现金流量净额(620,926)(394,203)(488,801)(1,062,016)(868,567)
汇率变动对现金及现金等价物的影响(19,169)(13,551)10,8327,38738,949
现金及现金等价物净增加/(减少)(618,131)423,283(27,150)(458,343)269,856
期初现金及现金等价物余额2,845,8082,422,5252,449,6742,908,0172,638,161
期末现金及现金等价物余额2,227,6772,845,8082,422,5252,449,6742,908,017